Overexpression of Msi1 in the advanced stages of the disease and also the prognosis associated with colon and breast cancers (83, 84), urothelial, esophageal, cervical cancer as well as central nervous system tumors, including glioma, medulloblastoma, and ependymoma is recorded (85-90). This evidence concerns the gene MSI1 and medulloblastoma.